Open AccessChemotherapy induced Takotsubo cardiomyopathy
Author(s) -
Sunny Goel,
Abhishek Sharma,
Aakash Garg,
Abhinav B. Chandra,
Vijay Shetty
Publication year - 2014
Publication title -
world journal of clinical cases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v2.i10.565
Subject(s) - medicine , cardiomyopathy , cytarabine , chemotherapy , daunorubicin , myeloid leukemia , cardiotoxicity , cardiology , heart failure
Chemotherapy has been linked with Takotsubo cardiomyopathy. Most of the literature on chemotherapy associated Takotsubo cardiomyopathy is on the drug 5-fluorouracil. In this report, we describe the case of a 55-year-old Asian male who developed Takotsubo cardiomyopathy while receiving dual chemotherapy with cytarabine and daunorubicin for acute myeloid leukemia. To our knowledge, it is the first case of Takotsubo cardiomyopathy associated with daunorubicin and/or cytarabine.